2002

1. Chu TY, Hwang KS, Yu MH, Lee HS, Lai HC, Liu JY(2002) A research-base tumor tissue bank of gynecologic oncology: characteristics of nucleic acids extracted from normaland tumor tissues from different sites. Int J Gynecol Cancer 12:171-176. (SCI)
2. Chen DC, Yu MH, Liu JY(2002) Complication of long-term indwelling Foley catheter: mimicry of ovarian malignancy. Taiwanese J Obstet Gynecol 41(2) 73-76
3. Ding DC, Yu MH, Liu JY(2002) Autocalcification of the ovary. Int J Gynecol Obstet, 79:249-250. (SCI)

2003

1. Chang YK. Chen WH. Yu MH. Liu HS(2003) Intracervical misoprostol and prostaglandin E2 for labor induction. Int J Gynecol Obstet, 80(1):23-8. (SCI)
2. Lai HC, Sytwu HK, Sun CA, Yu MH, Yu CP, Liu HS, Chang CC, Chu TY(2003) Single nucleotide polymorphism at FAS promoter is associated with cervical carcinogenesis. Int J Cancer:103, 221-225. (SCI)
3. Chang FW, Yu MH, Chen WH(2003) An angular pregnancy of a bicornuate uterus. Int J Gynecol Obstet, 81:219-220. (SCI)
4. Ding DC, Yu MH*, Wu CC, Liu JY(2003) Urachal myoma: a case report. Acta Obstet Gynecol Scand 82:481-483. (SCI)
5. Chan CC, Yu MH, Hwang KS, Wu GJ, Liu JY & Chu TY(2003) Can vesopressin decrease the blood loss in laparoscopic assisted vaginal hysterectomy? A randomized study. J Med Sci, 23(5): 281-284

2004

1. Chang FW, Ding DC, Chen DC, Yu MH*(2004) Heavy uterine bleeding due to uterine arteriovenous malformation. Acta Obstet Gynecol Scand 83:599-600. (SCI)
2. Ho CM, Huang YJ, Chen TC, Huang SH, Liu FS, ChangChien CC, Yu MH, Mao TL, Wang TY, Hsieh CY(2004) Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease. Gynecol Oncol 94:197-203. (SCI)
3. Huang RL, Chao CF, Ding DC, Yu CP, Chang CC, Lai HC, Yu MH, Liu HS, Chu TY(2004) Multiple epithelial and nonepithelial tumors in hereditary nonpolyposis colorectal cancer: characterization of germline and somatic mutations of the MSH2 gene and heterogeneity of replication error phenotypes. Cancer Genetics and Cytogenetics 153:108-114. (SCI)
4. Chang CC, Peng MY, Lai HC, Yu MH, Chu TY(2004) Anogenital lymphangioma circumscriptum masquerading as condyloma accuminata. Acta Obstet Gynecol Scand 83(11):1093-4. (SCI)
5. Ding DC, Chang FW, Yu MH*(2004) Huge clear cell carcinoma of the cervix in teenager not associated with diethylstilbestrol: a brief case report. Eur J Obstet Gyn R B 117:115-116 (SCI)
6. Chang FW, Yu MH, Wu CC, Chen WH, Chen CH(2004) Cornual pregnancy treated with dilatation and curettage under laparoscopic guidance: a report of two cases. Taiwanese J Obstet Gynecol 43(4):229-231

2005

1. Lai HC, Chu CM, Lin YW, Chang CC, Nieh S, Yu MH, Chu TY(2005) Matrix metalloproteinase 1 gene polymorphism as a prognostic predictor of invasive cervical cancer. Gynecol Oncol 96:314-319. (SCI)
2. Lai HC, Chang CC, Lin YW, Chen SF, Yu MH, Nieh S, Chu TW, Chu TY(2005) Genetic polymorphism of the interferon-gamma gene in cervical carcinogenesis. Int J Cancer 113(5):712-8 (SCI)
3. Chen DC, Chen CH, Su HY, Yu CP, Yu MH(2005) Retroperitoneal lymphangiomyomas presenting as a pelvic mass. Acta Obstet Gyn Scan 84(9):917-20. (SCI)
4. Wang YC, Lu JJ, Chen CH, Peng YJ, Yu MH*(2005) Peritoneal tuberculosis mimicking ovarian cancer can be diagnosed by polymerase chain reaction: A case report. Gynecol Oncol 97:961-963. (SCI)
5. Lai HC, Lin WY, Lin YW, Chang CC Yu MH, Chen CC, Chu TY(2005) Genetic polymorphisms of FAS and FASL(CD95/CD95L) genes in cervical carcinogenesis:An analysis of haplotype and gene-gene interaction. Gynecol Oncol 99(1):113-8. (SCI)

2006

1. Chang FW, Yu MH, Ku CH, Chen CH, Wu GJ, Liu JY(2006) Effect of uterotonics on intra-operative blood loss during laparoscopy-assisted vaginal hysterectomy:a randomized controlled trial. BJOG 113:47-52. (SCI)
2. Chang WH, Chen CH, Yu MH*(2006) Conservative therapy of stage I endometrial adenocarcinoma and atypical endometrial hyperplasia for the preservation of fertility. Int J Gynecol Obstet, 92:137-138. (SCI)
3. Wang YC, Chen CH, Su HY, Yu MH*(2006) The impact of maternal cardioversion on fetal haemodynamics. Eur J Obstet Gyn R B 126(2):268-9. (SCI)
4. Lin YW, Lin CY, Lai HC, Chiou JY, Chang CC, Yu MH, Chu TY(2006) Plasma proteomic pattern as biomarkers for ovarian cancer. Int J Gynecol cancer 16Suppl 1:139-46 (SCI)
5. Lin CK, Yu MH, Chu TW , Lai HC *Synchronous occurrence of primary neoplasms in the uterus with squamous cell carcinoma of the cervix and adenocarcinoma of the endometrium. Taiwan J Obstet Gynecol. 2006 Dec;45(4):336-9

1. Lin CK, Chu TW , Yu MH* Painless ovarian torsion Mimicking a uterine myoma Taiwan J Obstet Gynecol.2006 Dec;45(4):340-342

 

1. Chu PW, Liu JY, Peng YJ , Yu MH * Solitary fibrous tumor of the uterus. Taiwan J Obstet Gynecol 2006 Dec;45(4):350-2.

2007

1. Lai HC, Lin YW, Chang CC, Wang HC, Chu TW, Yu MH, Chu TY(2007). Hypermethylation in cervical neoplasma of two tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 Gynecol Oncol. (SCI) 2007 Mar;104(3):629-35
2. Wu CJ, Peng YJ , Yu MH, Chen CH *Secretory endometrial adenocarcinoma in a tamoxifen user with breast cancer after menopause Taiwan J Obstet Gynecol 2007 Mar;46(1):88-90

1. Mao SP , Lai HC , Chang FW, Yu MH , Chang CC* Laparoscopy-assisted robotic myomectomy using the da Vinci system Taiwan J Obstet Gynecol 2007 Jun;46(2):174-6

2008

1. Lin CT. Lai HC. Lee HY. Lin WH. Chang CC. Chu TY. Lin YW. Lee KD. Yu MH*(2008) Valproic acid resensitizes cisplatin- resistant ovarian cancer cells. Cancer Sci. 99(6):1218-26. (SCI)
2. Lai HC. Lin YW. Huang TH. Yan P. Huang RL. Wang HC. Liu J. Chan MW. Chu TY. Sun CA. Chang CC. Yu MH (2008) Identification of Novel DNA Methylations in Cervical Cancer. Int J Cancer.123(1):161-7. (SCI)
3. Ding DC, Hsu HC, Huang RL, Lai HC, Lin CY, Yu MH, Chu TY (2008)Type-specific distribution of HPV along the full spectrum of cervical carcinogenesis in Taiwan: an indication of viral oncogenic potential Eur J Obstet Gynecol Reprod Biol. 2008 Oct;140(2):245-51.

2009

1. Su HY, Lai HC*, Lin YW, Chou YC, Liu CY, Yu MH*.( 2009) An Epigenetic Marker Panel for Screening and Prognostic Prediction of Ovarian Cancer. Int J Cancer. 2009 Jan 15;124(2):387-93 (*Corresponding Author) (SCI)
2. Chung MT, Sytwu HK, Yan MD, Shih YL, Chang CC, Yu MH, Chu TY, Lai HC*, Lin YW*.(2009)Promoter Methylation of SFRPs Gene Family in Cervical Cancer. Gynecol Oncol. Feb;112(2):301-6. (*Corresponding Author) (SCI)
3. Chung MT, Lai HC, Sytwu HK, Yan MD, Shih YL, Chang CC, Yu MH, Liu HS, Chu DW, Lin YW.(2009)SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway. Gynecol Oncol.. 2009 Mar;112(3):646-53 (SCI)
4. Lin CK, Chao TK, Yu CP, Yu MH ., Jin JS (2009)The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters. APMIS. 2009 Mar;117(3):162-75.
5. Lu CC, Lin TC, Yu MH, Chen TL, Lin CY, Chiang JS, Ho ST(2009) Effects of changes in alveolar ventilation on isoflurane arterial blood concentration and its uptake into the human body..Pharmacology. 2009;83(3):150-6.
6. Sun CC, Chang CC, Yu MH. (2009)Far-migrated intra-abdominal intrauterine device with abdominal pain. Taiwan J Obstet Gynecol. 2008 Jun;47(2):244-6
7. Lin CK, Chang CC, Pan SH, Yu MH (2009)Primary fallopian tube cancer may mimic endometrial malignancy.. Taiwan J Obstet Gynecol. 2008 Jun;47(2):218-9.
8. Liu CY, Chao TK, Su PH, Lee HY, Shih YL, Su HY, Chu TY, Yu MH, Lin YW *, Lai HC* Characterization of LMX-1A as a metastasis suppressor in cervical cancer. Journal of Pathology 2009 Oct;219(2):222-31 (*Corresponding Author) (SCI) (IF:6.466; Rank:2/71=2.82%)
9. Fu PT, Chen CH, Wu GJ, Yu MH *Successful management of gravid uterine rupture Taiwan J Obstet Gynecol.2009 Sep; 48(3):319-20

2010

1. Lai HC* Lin YW ; Huang RL, Chung MT; Wang HC, Liao YP, Su PH, Yu MH, Quantitative DNA methylation analysis detects cervical intraepithelial neoplasm 3 and worse? Cancer 2010 Jun 8. (SCI) . (IF:5.418; Rank:20/165=12.12%)
2. Tan SJ, Juan YH, Fu PT, Yu,MH, ?Lai HC* Chemotherapy with low dose bevacizumab and carboplatin in the treatment of a patient with recurrent cervical cancer Eur J of Gyn Onc no.3,2010 ?(SCI) (IF:0.614;Rank:60/70=85.7%)
3. Su HY, Lai HC Lin YW, Liu CY, Chou YC, Lin SP, Lin WC, Yu MH*, Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway.Int. J. Cancer 2010 Aug 1;127(3):555-67. (SCI) (IF:4.722;Rank:29/165=17.58%)
4. Liu YL, Tsai1 SH, Chang FW, Yu MH*Ifosfamide-induced encephalopathy in patients with uterine sarcoma. Taiwan J Obstet Gynecol..2010 Mar;49(1):77-80

上一頁